SCHEMBL5500593

SCHEMBL5500593

CC(=O)CCN1CCNC(C)C1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
BIRC2 Q13490 10/20 0.53
XIAP P98170 7/20 0.39
GRIN2D O15399 2/20 0.38
GRIN3B O60391 2/20 0.38
THRB P10828 2/20 0.38
GRIN1 Q05586 2/20 0.38
GRIN2A Q12879 2/20 0.38
GRIN2B Q13224 2/20 0.38
GRIN2C Q14957 2/20 0.38
GRIN3A Q8TCU5 2/20 0.38
CYP1A2 P05177 1/20 0.38
ALOX15 P16050 1/20 0.38
CYP2C19 P33261 1/20 0.38
HSD17B10 Q99714 1/20 0.38
LMNA P02545 1/20 0.38
RECQL P46063 1/20 0.38
PAOX Q6QHF9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11207344 0.86 BIRC2 (0.53) BIRC2XIAPGRIN2DGRIN3BTHRB
SCHEMBL16509233 0.81 BIRC2 (0.65) BIRC2XIAP
SCHEMBL13993896 0.79 SIGMAR1 (0.38) BIRC2CYP1A2ALOX15CYP2C19PAOX
SCHEMBL28233194 0.79 BIRC2 (0.50) BIRC2XIAPGRIN2DGRIN3BTHRB
SCHEMBL28233170 0.79 BIRC2 (0.50) BIRC2XIAPGRIN2DGRIN3BTHRB
SCHEMBL28234131 0.79 BIRC2 (0.50) BIRC2XIAPGRIN2DGRIN3BTHRB
SCHEMBL19107795 0.79 BIRC2 (0.47) BIRC2XIAPLMNA
SCHEMBL18723951 0.79 BIRC2 (0.47) BIRC2XIAPLMNA
SCHEMBL18723959 0.79 BIRC2 (0.47) BIRC2XIAPLMNA
SCHEMBL14530951 0.78 BIRC2 (0.49) BIRC2XIAPGRIN2DGRIN3BTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1861376-A1 CIS-2,4,5-TRIARYL-IMIDAZOLINES AND THEIR USE AS ANTI-CANCER MEDICAMENTS F. Hoffmann-Roche AG (CH) 2007-12-05 EP disclosed
WO-2006097261-A1 CIS-2,4,5-TRIARYL-IMIDAZOLINES AND THEIR USE AS ANTI-CANCER MEDICAMENTS F.HOFFMANN-LA ROCHE AG (CH) 2006-09-21 WO disclosed